X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (103408) 103408
Newsletter (14689) 14689
Book Review (13684) 13684
Publication (8560) 8560
Newspaper Article (4816) 4816
Book Chapter (854) 854
Conference Proceeding (789) 789
Dissertation (266) 266
Government Document (147) 147
Magazine Article (100) 100
Web Resource (72) 72
Trade Publication Article (54) 54
Reference (46) 46
Book / eBook (26) 26
Data Set (8) 8
Transcript (6) 6
Streaming Video (5) 5
Paper (4) 4
Journal / eJournal (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (80260) 80260
humans (58733) 58733
epidermal growth factor (50163) 50163
animals (37235) 37235
female (25228) 25228
oncology (24332) 24332
cancer (21667) 21667
research (20354) 20354
male (18739) 18739
mice (16849) 16849
receptor, epidermal growth factor - metabolism (15343) 15343
cell biology (14406) 14406
biochemistry & molecular biology (14236) 14236
expression (12983) 12983
middle aged (11770) 11770
signal transduction (11418) 11418
mutation (11185) 11185
epidermal growth factor - pharmacology (11157) 11157
epidermal-growth-factor (10682) 10682
receptor, epidermal growth factor - genetics (10641) 10641
phosphorylation (10395) 10395
proteins (10373) 10373
aged (9766) 9766
adult (9750) 9750
analysis (9504) 9504
epidermal growth-factor (9422) 9422
cell line, tumor (9305) 9305
cells, cultured (9218) 9218
rats (9165) 9165
genetic aspects (8965) 8965
care and treatment (8919) 8919
tumors (8614) 8614
breast cancer (8226) 8226
receptor, epidermal growth factor - antagonists & inhibitors (8019) 8019
epidermal growth factor receptor (7870) 7870
gene expression (7820) 7820
chemotherapy (7743) 7743
kinases (7335) 7335
lung cancer (7329) 7329
immunohistochemistry (7322) 7322
metastasis (7168) 7168
egfr (7072) 7072
cell line (6981) 6981
epidermal growth factor receptors (6906) 6906
growth-factor receptor (6905) 6905
apoptosis (6891) 6891
cells (6822) 6822
epidermal growth factor - metabolism (6637) 6637
reports (6408) 6408
prognosis (6296) 6296
activation (6106) 6106
lung cancer, non-small cell (5764) 5764
tyrosine (5699) 5699
oncology, experimental (5696) 5696
health aspects (5684) 5684
gefitinib (5305) 5305
physiological aspects (5269) 5269
multidisciplinary sciences (5057) 5057
article (4991) 4991
antineoplastic agents - therapeutic use (4853) 4853
medicine (4816) 4816
research article (4797) 4797
cell proliferation (4791) 4791
molecular sequence data (4764) 4764
cancer therapies (4647) 4647
tumor cells, cultured (4557) 4557
aged, 80 and over (4454) 4454
pharmacology & pharmacy (4445) 4445
lung neoplasms - genetics (4443) 4443
lung neoplasms - drug therapy (4438) 4438
universities and colleges (4225) 4225
therapy (4198) 4198
abridged index medicus (4171) 4171
patients (4111) 4111
biochemistry (4034) 4034
medical research (4017) 4017
survival (4016) 4016
signal transduction - drug effects (4007) 4007
growth factors (3963) 3963
gene-expression (3961) 3961
development and progression (3942) 3942
proliferation (3891) 3891
amino acid sequence (3884) 3884
pathology (3869) 3869
antineoplastic agents - pharmacology (3842) 3842
protein (3838) 3838
genes (3836) 3836
factor receptor (3820) 3820
in-vitro (3818) 3818
growth (3772) 3772
rodents (3728) 3728
carcinoma (3670) 3670
cell division - drug effects (3667) 3667
differentiation (3666) 3666
carcinoma, non-small-cell lung - drug therapy (3659) 3659
receptor (3641) 3641
time factors (3616) 3616
lung neoplasms - pathology (3598) 3598
ligands (3581) 3581
surgery (3549) 3549
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (120429) 120429
Chinese (1304) 1304
Japanese (693) 693
French (496) 496
German (370) 370
Russian (314) 314
Spanish (221) 221
Korean (193) 193
Polish (89) 89
Hungarian (47) 47
Italian (43) 43
Portuguese (35) 35
Czech (31) 31
Turkish (29) 29
Dutch (12) 12
Bulgarian (11) 11
Danish (9) 9
Croatian (7) 7
Hebrew (7) 7
Ukrainian (7) 7
Persian (6) 6
Finnish (4) 4
Norwegian (4) 4
Romanian (4) 4
Swedish (4) 4
Lithuanian (3) 3
Serbian (2) 2
Slovak (2) 2
Catalan (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1990, ISBN 9780121531249, Volume 24., xv, 347
Book
The New England Journal of Medicine, ISSN 0028-4793, 09/2009, Volume 361, Issue 10, pp. 958 - 967
Journal Article
1981, ISBN 9783540106234, Volume 57., xxii, 630
Book
Archives of Pathology and Laboratory Medicine, ISSN 0003-9985, 02/2014, Volume 138, Issue 2, pp. 241 - 256
Journal Article
Journal Article
Nature Medicine, ISSN 1078-8956, 03/2016, Volume 22, Issue 3, pp. 262 - 269
Journal Article
Nature, ISSN 0028-0836, 2014, Volume 506, Issue 7487, pp. 230 - 234
There are no clinically relevant treatments available that improve function in the growing population of very preterm infants (less than 32 weeks' gestation)... 
MULTIPLE-SCLEROSIS | LOW-BIRTH-WEIGHT | OLIGODENDROCYTE PROGENITORS | MULTIDISCIPLINARY SCIENCES | HYPOXIC INJURY | CENTRAL-NERVOUS-SYSTEM | MOUSE CORPUS-CALLOSUM | PRETERM INFANTS | RAT-BRAIN | WHITE-MATTER ABNORMALITIES | FACTOR RECEPTOR | Epidermal Growth Factor - administration & dosage | Oligodendroglia - metabolism | Receptor, Epidermal Growth Factor - genetics | Demyelinating Diseases - congenital | Brain Injuries - drug therapy | Humans | Brain Injuries - congenital | Male | Stem Cells - cytology | Demyelinating Diseases - metabolism | Epidermal Growth Factor - therapeutic use | Molecular Targeted Therapy | Stem Cells - metabolism | Cell Lineage - drug effects | Hypoxia - metabolism | Receptor, Epidermal Growth Factor - metabolism | Oligodendroglia - drug effects | Time Factors | Oligodendroglia - cytology | Demyelinating Diseases - pathology | Disease Models, Animal | Animals, Newborn | Cell Survival - drug effects | Demyelinating Diseases - prevention & control | Administration, Intranasal | Infant, Premature, Diseases - drug therapy | Cell Division - drug effects | Brain Injuries - prevention & control | Oligodendroglia - pathology | Hypoxia - genetics | Regeneration - drug effects | Animals | Signal Transduction - drug effects | Cell Differentiation - drug effects | Hypoxia - pathology | Stem Cells - drug effects | Hypoxia - physiopathology | Infant, Premature, Diseases - metabolism | Mice | Epidermal Growth Factor - pharmacology | Brain Injuries - pathology | Infant, Premature, Diseases - pathology | Brain | Medical research | Care and treatment | Infants (Premature) | Risk factors | Complications and side effects | Epidermal growth factor | Physiological aspects | Medicine, Experimental | Hypoxia | Diagnosis | Health aspects | Injuries | Attention deficit disorder | Brain damage | Rodents | Apoptosis | Index Medicus
Journal Article
Nature, ISSN 0028-0836, 07/2012, Volume 487, Issue 7408, pp. 505 - 509
Mutationally activated kinases define a clinically validated class of targets for cancer drug therapy(1). However, the efficacy of kinase inhibitors in... 
CELL LUNG-CANCER | SURVIVAL | HETEROGENEITY | ACTIVATION | RECEPTOR TYROSINE KINASES | THERAPY | MET AMPLIFICATION | MULTIDISCIPLINARY SCIENCES | ACQUIRED-RESISTANCE | SENSITIVITY | TUMOR-CELLS | Receptor, ErbB-2 - genetics | Humans | Receptor, ErbB-2 - metabolism | Melanoma - enzymology | Phosphatidylinositol 3-Kinases - metabolism | Hepatocyte Growth Factor - pharmacology | Breast Neoplasms - metabolism | Melanoma - genetics | Female | Indoles - pharmacology | Antineoplastic Agents - pharmacology | Cell Survival - drug effects | Melanoma - pathology | Receptor Protein-Tyrosine Kinases - metabolism | Sulfonamides - pharmacology | Breast Neoplasms - drug therapy | Hepatocyte Growth Factor - metabolism | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Breast Neoplasms - genetics | Signal Transduction - drug effects | Breast Neoplasms - pathology | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Cell Line, Tumor | Ligands | Protein Kinase Inhibitors - pharmacology | Quinazolines - pharmacology | Drug Resistance, Neoplasm - drug effects | Mitogen-Activated Protein Kinases - metabolism | Antimitotic agents | Physiological aspects | Antineoplastic agents | Growth factors | Health aspects | Phosphotransferases | Substance abuse treatment | Epidermal growth factor | Rodents | Biomarkers | Breast cancer | Insulin-like growth factors | Kinases | Drug resistance | Tumors | Index Medicus
Journal Article
JAMA, ISSN 0098-7484, 10/2003, Volume 290, Issue 16, pp. 2149 - 2158
Journal Article
Nature, ISSN 0028-0836, 10/2015, Volume 526, Issue 7572, pp. 263 - 267
Colorectal cancer is the third most common cancer worldwide, with 1.2 million patients diagnosed annually. In late-stage colorectal cancer, the most commonly... 
PANITUMUMAB | THERAPY | MULTIDISCIPLINARY SCIENCES | SEQUENCE | ACQUIRED-RESISTANCE | SOMATIC MUTATION | IDENTIFICATION | GENE COPY NUMBER | ACTIVATING MUTATIONS | BREAST | INSIGHTS | Receptor, Epidermal Growth Factor - genetics | Receptor, ErbB-2 - genetics | Proto-Oncogene Proteins p21(ras) - genetics | Colorectal Neoplasms - genetics | Genomics | Humans | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Cetuximab - therapeutic use | Molecular Targeted Therapy | Receptor, Fibroblast Growth Factor, Type 1 - genetics | MAP Kinase Kinase 1 - genetics | Colorectal Neoplasms - drug therapy | Female | Antineoplastic Agents - pharmacology | Insulin Receptor Substrate Proteins - genetics | Colorectal Neoplasms - metabolism | Antibodies, Monoclonal - pharmacology | Cetuximab - pharmacology | DNA Copy Number Variations - genetics | Mutation - genetics | Genome, Human - genetics | Receptor, Epidermal Growth Factor - chemistry | Xenograft Model Antitumor Assays | Drug Resistance, Neoplasm - genetics | Exome - genetics | Animals | Receptor, Platelet-Derived Growth Factor alpha - genetics | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Mice | Drug Resistance, Neoplasm - drug effects | Care and treatment | Gene mutations | Colorectal cancer | Drug metabolism | Genetic aspects | Identification and classification | Health aspects | Proteins | Epidermal growth factor | Genes | Clinical trials | Mutation | Kinases | Cancer therapies | Tumors | Index Medicus
Journal Article